Today I learned that WiFi and Bluetooth LE could NOT be used simultaneously on Arduino boards featuring the ESP32-based u-blox NINA-W102 wireless module, ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

There have been many questions about what direction Arduino would take after being bought by Qualcomm. Now it would seem that we’re getting a clearer picture. Perhaps unsurprisingly the answer appears ...

U.S. antitrust enforcers should consider blocking a bid by Compass, the nation’s largest residential real estate broker, to acquire rival Anywhere Real Estate, amid a housing shortage, two Democratic ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...

The Jeep Compass Sandstorm Edition has been launched with prices ranging from Rs 19.49 lakh to Rs 27.33 lakh (ex-showroom). It is primarily being offered as an additional kit with a few cosmetic ...

Jeep adds Uconnect handsfree and satellite radio as standard equipment and the Latitude trim receives automatic headlights as standard. The Sport SE package and a Mojave Sand exterior color were also ...

You will get access to the full Best Colleges rankings, comprehensive information on each school, and premium tools and features. Subscribing to College Compass unlocks: Try our My Fit Custom Ranking ...

Compass, Inc. engages in the provision of an online real estate platform. Its platform provides an integrated suite of software for customer relationship management, marketing, client service, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.